Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 23201081)

1.

Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.

De Smedt D, Clays E, Annemans L, Doyle F, Kotseva K, Pająk A, Prugger C, Jennings C, Wood D, De Bacquer D.

Int J Cardiol. 2013 Sep 30;168(2):898-903. doi: 10.1016/j.ijcard.2012.10.053. Epub 2012 Nov 30.

PMID:
23201081
2.

EQ-5D versus SF-12 in coronary patients: are they interchangeable?

De Smedt D, Clays E, Annemans L, De Bacquer D.

Value Health. 2014 Jan-Feb;17(1):84-9. doi: 10.1016/j.jval.2013.10.010.

PMID:
24438721
3.

Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients.

De Smedt D, Clays E, Doyle F, Kotseva K, Prugger C, Pająk A, Jennings C, Wood D, De Bacquer D; EUROASPIRE Study Group.

Int J Cardiol. 2013 Sep 1;167(5):2294-9. doi: 10.1016/j.ijcard.2012.06.025. Epub 2012 Jun 28.

PMID:
22748284
4.

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events.

Lancet. 2001 Mar 31;357(9261):995-1001.

PMID:
11293642
6.

Secondary prevention in patients with coronary heart diseases: what factors are associated with health status in usual primary care?

Ose D, Rochon J, Campbell SM, Wensing M, van Lieshout J, Uhlmann L, Freund T, Szecsenyi J, Ludt S.

PLoS One. 2012;7(12):e51726. doi: 10.1371/journal.pone.0051726. Epub 2012 Dec 26.

7.

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37. doi: 10.1097/HJR.0b013e3283294b1d.

PMID:
19287307
9.

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.

PMID:
19286092
10.
11.

The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey.

De Smedt D, Clays E, Annemans L, Boudrez H, De Sutter J, Doyle F, Jennings C, Kotseva K, Pająk A, Pardaens S, Prugger C, Wood D, De Bacquer D.

Eur J Prev Cardiol. 2014 Jul;21(7):796-805. doi: 10.1177/2047487312473846. Epub 2013 Jan 10.

PMID:
23307830
12.

Associations between demographic, disease related, and treatment pathway related variables and health related quality of life in primary care patients with coronary heart disease.

Kramer L, Hirsch O, Schlössler K, Träger S, Baum E, Donner-Banzhoff N.

Health Qual Life Outcomes. 2012 Jul 9;10:78. doi: 10.1186/1477-7525-10-78.

13.

Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.

Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P; EUROASPIRE Study Group.

Heart. 2010 Nov;96(21):1744-9. doi: 10.1136/hrt.2010.196170.

PMID:
20956490
14.

Blood pressure is insufficiently controlled in European patients with established coronary heart disease.

Boersma E, Keil U, De Bacquer D, De Backer G, Pyörälä K, Poldermans D, Leprotti C, Pilotto L, de Swart E, Deckers JW, Heidrich J, Sans S, Kotseva K, Wood D, Ambrosio GB; EUROASPIRE I and II Study Groups.

J Hypertens. 2003 Oct;21(10):1831-40.

PMID:
14508188
15.

[Influence of chronic diseases on health related quality of life in middle-aged and elderly people from rural communities: application of EQ-5D scale on a Health Survey in Fangshan, Beijing].

Cao Y, Tang X, Yang L, Li N, Wu YQ, Fan WY, Liu JJ, Yu LP, Xu HT, Liu WJ, Wen SS, Hu YH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jan;33(1):17-22. Chinese.

PMID:
22575103
16.

Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.

Ludt S, Wensing M, Szecsenyi J, van Lieshout J, Rochon J, Freund T, Campbell SM, Ose D.

PLoS One. 2011;6(12):e29334. doi: 10.1371/journal.pone.0029334. Epub 2011 Dec 22.

17.
18.

Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.

Pajak A, Jankowski P, Kawecka-Jaszcz K, Surowiec S, Wolfshaut R, Loster M, Batko K, Badacz L, Dubiel JS, Grodecki J, Grodzicki T, Maciejewicz J, Mirek-Bryniarska E, Piotrowski W, Smielak-Korombel W, Tracz W.

Kardiol Pol. 2009 Dec;67(12):1353-9.

19.

Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.

Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, Reiner Z, Gaita D, Wood D, Kotseva K, Heidrich J; EUROASPIRE III Study Group.

J Hypertens. 2011 Aug;29(8):1641-8. doi: 10.1097/HJH.0b013e328348efa7.

PMID:
21720270
20.

Efficacy of a long-term secondary prevention programme following inpatient cardiovascular rehabilitation on risk and health-related quality of life in a low-education cohort: a randomized controlled study.

Mayer-Berger W, Simic D, Mahmoodzad J, Burtscher R, Kohlmeyer M, Schwitalla B, Redaèlli M.

Eur J Prev Cardiol. 2014 Feb;21(2):145-52. doi: 10.1177/2047487312465526. Epub 2012 Oct 30.

PMID:
23111536
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk